Results from two concurrent, prospective, double-blind, multi-center clinical trials show that pegaptanib (Macugen), an anti-vascular endothelial growth factor therapy, is an effective treatment for neovascular age-related macular degeneration (AMD).
Researchers have found that Chlamydia pneumoniae, a bacterium linked to heart disease and capable of causing chronic inflammation, was present in the diseased eye tissue of five out of nine people with neovascular, or "wet," age-related macular degeneration.
It is estimated that up to half of U.S. women suffer from some level of female pelvic floor disorders, a group of conditions that includes pelvic organ prolapse, urinary incontinence, and other sensory and emptying abnormalities of the lower urinary tract.
The Massachusetts Eye and Ear Infirmary (MEEI) is observing Healthy Vision Month in May, sponsored by the National Eye Institute (NEI), along with the National Institute of Safety and Health. Statistics from the NEI indicate that more than 2,000 U.S. workers receive medical treatment because of work-related eye injuries, with more than 800,000 eye injuries occurring annually.
Researchers report for the first time how two behavioral lifestyle factors together alter the genetic susceptibility to age-related macular degeneration (AMD), associated with the common coding variant in the complement factor H (CFH) gene, Y402H.
Research conducted by participants at several medical schools, including co-authors Michael J. Cunningham, M.D., and Roland D. Eavey, M.D., of the Massachusetts Eye and Ear Infirmary Pediatric Otolaryngology Service, Department of Otology and Laryngology, Harvard Medical School, has found that reducing the amount of work hours alone for surgical residents does not appear to improve quality of patient care. The study is published in the October issue of the Journal of Surgical Research.
The Massachusetts Eye and Ear Infirmary (MEEI) announces that yesterday, in the United States District Court for the District of Massachusetts, a jury found in favor of MEEI on claims of unjust enrichment and unfair trade practices against QLT Inc.
The Massachusetts Eye and Ear Infirmary (MEEI) announces that today, in the United States District Court for the District of Massachusetts, Judge William G. Young, following a Nov. 6, 2006 jury decision, ruled in favor of MEEI on claims of unjust enrichment and unfair trade practices against QLT Inc.
The Massachusetts Eye and Ear Infirmary (MEEI) ranked in the top five hospitals in the nation for ear, nose and throat and for ophthalmology (eyes), according to U.S. News & World Report's 2007 "America's Best Hospitals" survey.
Recent studies have explored the use of an implantable prosthetic device -- an implantable miniature telescope -- for end-stage age-related macular degeneration. While the device has not yet been approved by the Food and Drug Administration, physicians have described a recommended surgical technique to ensure proper product placement while minimizing damage to the eye. Their technique is published in the August issue of the Archives of Ophthalmology.
The Massachusetts Eye and Ear Infirmary (Mass. Eye and Ear) announces that yesterday the United States Court of Appeals for the First Circuit affirmed a lower court's decision in favor of Mass. Eye and Ear on claims of unjust enrichment and unfair trade practices against QLT Inc.
A study looking at the electronic medical records of 100 consecutive people who came to the Massachusetts Eye and Ear Infirmary for hearing tests that revealed substantial hearing loss in both ears found that only 28 percent of these people were noted by their primary care doctors to have hearing loss and 36 percent were noted to have normal hearing. This study suggests that hearing loss is under-recognized and/or underreported by general medical doctors.
Researchers at the Massachusetts Eye and Ear Infirmary and Schepens Eye Research Institute have concluded that short-term topical bevacizumab therapy reduces the severity of corneal neovascularization (formation of new blood vessels in the cornea that can create impaired vision or vision loss) without local or systemic adverse effects.
Surgeons from Massachusetts Eye and Ear Infirmary and Mass. General Hospital will perform the first Auditory Brain Stem Implant (ABI) surgery in New England on May 20. The ABI, which can restore the sense of hearing to certain patients, has been implanted in about 500 people worldwide.
Research and educational programs at the Massachusetts Eye and Ear Infirmary have received a $126 million boost with the recent resolution of a nearly decade-long lawsuit concerning the hospital's role in the development of Visudyne, the first drug treatment for wet age-related macular degeneration.
On Nov. 30, 2009 the Massachusetts Eye and Ear Infirmary discovered that a patient’s credit card had been inappropriately used on Nov. 11 and 12 by a Mass. Eye and Ear employee.
Wycliffe “Wyc” Grousbeck, co-owner and chief executive officer of the Boston Celtics and an avid supporter of initiatives relating to blindness, was elected chair of the Foundation and the Board of Directors of the Massachusetts Eye and Ear Infirmary on Jan. 26.
On February 19, 2010, a laptop belonging to a physician affiliated with the Massachusetts Eye and Ear Infirmary was stolen while the physician was lecturing in South Korea. Mass. Eye and is alerting patients to this data breach.
Joey McIntyre and The New Kids on the Block will lend their voices to launch the new Cures for Kids Fund at Mass. Eye and Ear during Sense-ation!, a gala being held Oct. 13 at the Renaissance Boston Waterfront Hotel.
The Massachusetts Eye and Ear Infirmary wants the public, patients and their families to stay safe on Halloween. There are several tips that parents can mind to keep their children safe.
The Massachusetts Eye and Ear Infirmary consistently promotes eye health and regular vision screenings as part of it’s mission – and this month the hospital is highlighting healthy sight during the month of May. May is the Healthy Vision Month, an annual observance established by the National Eye Institute.
Clinician scientist Eric Pierce, M.D., Ph.D., will join the Massachusetts Eye and Ear Infirmary and Harvard Department of Ophthalmology in September as Associate Director of the Berman-Gund Laboratory for the Study of Retinal Degenerations, as a clinician and educator, and as Director of the new Ocular Genomics Institute, where he will direct the Genetic Therapies program.
Boston (June 8, 2011) – The Massachusetts Eye and Ear Infirmary and Schepens Eye Research Institute announced today that they are combining forces to create the world’s largest and most robust basic and clinical ophthalmology research enterprise with full spectrum bench-to-bedside research that will translate more quickly into better treatment for blinding diseases and ultimately cures.
Mass. Eye and Ear is pleased to announce that Drs. David Kam, Cathy Chong, and Amee Dharia of the Weymouth based South Suburban Ear, Nose, Throat Associates have joined Mass. Eye and Ear’s physician practice as part of the South Suburban Center of Otolaryngology, effective Dec. 1, 2011.
Results from the largest genetic study of glaucoma, a leading cause of blindness and vision loss worldwide, showed that two genetic variations are associated with primary open angle glaucoma (POAG), a common form of the disease.
Researchers from the Massachusetts Eye and Ear Infirmary, The Children's Hospital of Philadelphia, Loyola University Chicago Health Sciences Division and their collaborators have isolated an elusive human gene that causes a common form of Leber congenital amaurosis (LCA), a relatively rare but devastating form of early-onset blindness. The new LCA gene is called NMNAT1. Finding the specific gene mutated in patients with LCA is the first step towards developing sight-saving gene therapy.
Corticosteroids are often given to children undergoing tonsillectomy to reduce postoperative nausea and vomiting; however, previous research has suggested that corticosteroids may increase the risk of hemorrhage during and after surgery. Researchers from the Massachusetts Eye and Ear, Boston, Naval Medical Center Portsmouth, Virginia, and colleagues set to determine the effect of dexamethasone, a corticosteroid, on bleeding. They found that administration of the dexamethasone to children during a tonsillectomy was not associated with excessive, serious bleeding events following surgery compared to patients who received placebo.
Schepens Eye Research Institute, Massachusetts Eye and Ear has named Patricia D’Amore, Ph.D., MBA, FARVO, as Director of Research at Schepens Eye Research Institute.
Massachusetts Eye and Ear, along with the Beal Companies, LLP, today celebrated the grand opening of its new outpatient surgical center at 800 Huntington Avenue in the Longwood/Mission Hill area of Boston.
Dr. Joan W. Miller was selected by the American Academy of Ophthalmology to deliver the prestigious Edward Jackson Memorial Lecture. She discussed research developments in age-related macular degeneration (AMD), a leading cause of blindness.
Massachusetts Eye and Ear, Longwood, a new outpatient surgical center at 800 Huntington Avenue in the Longwood/Mission Hill area of Boston, opened today to patients.
Reza Dana, M.D., M.P.H., M.Sc. of Mass. Eye and Ear/Harvard Medical School, was awarded the Research to Prevent Blindness (RPB) Senior Scientific Investigator Award in the amount of $150,000 to support research into the causes, treatment and prevention of blinding diseases.
A new measure of the heterogeneity – the variety of genetic mutations – of cells within a tumor appears to predict treatment outcomes of patients with the most common type of head and neck cancer.
The Massachusetts Eye and Ear Infirmary, a Harvard Medical School teaching affiliate, is now enrolling a select group of deaf infants and children in a new clinical trial of an Auditory Brainstem Implant (ABI).
Massachusetts Eye and Earhas opened the new Office of Global Surgery and Health, which will enhance global surgical and health education and outreach to address the growing need for ophthalmologists and otolaryngologists in the developing world.
Investigators at Massachusetts Eye and Ear have published the most thorough description of gene expression in the human retina reported to date.
Massachusetts Eye and Ear researchers describe the relatively simple technique of fundus photography in eyes using a smartphone, an inexpensive app for the smartphone, and instruments that are readily available in an ophthalmic practice.
Short-term hearing loss during childhood may lead to persistent hearing deficits, long after basic auditory sensitivity has returned to normal. Mass. Eye and Ear researchers gain new insight into how this works.
Parent-Scientists collaborate with son's physician to find way to screen children for eye cancer using digital photography.
A multi-center study (NCT00494676) led by Alex Bowers, Ph.D., Assistant Professor of Ophthalmology at HMS and Assistant Scientist at Massachusetts Eye and Ear/Schepens Eye Research Institute, determined that real peripheral prism glasses are more helpful than sham peripheral prism glasses for patients with hemianopia during every day walking.
Mass. Eye and Ear’s Office of Global Surgery and Health (OGSH) is launching a new collaboration with Mbarara University Science and Technology School of Medicine and Mbarara Regional Referral Hospital to help address the need for more trained physicians to care for the ENT diseases and conditions of this population and to help encourage those who are ENT trained to stay in the country to care for those who need them.
D. Bradley Welling, M.D., Ph.D., F.A.C.S., has been named the next Chief of Otolaryngology for the Massachusetts Eye and Ear /Massachusetts General Hospital departments, Chairman of Otology and Laryngology for Harvard Medical School.
The Massachusetts Eye and Ear/Harvard Medical School Department of Ophthalmology today announced the availability of a comprehensive genetic diagnostic test for inherited eye diseases, first in northeast to offer this service.
A recent paper by Mass. Eye and Ear/Harvard Medical School researchers in collaboration with researchers at the Ecole Normale Superieure, France, challenge the two dominant theories of how people localize sounds, explain why neuronal responses to sounds are so diverse and show how sound can be localized, even with the absence of one half of the brain. Their research is described on line in the journal eLife.
Researchers at Massachusetts Eye and Ear/Harvard Medical School Department of Ophthalmology, Boston Children’s Hospital, and the Massachusetts Institute of Technology are one step closer to an eye drop-free reality with the development of a drug-eluting contact lens designed for prolonged delivery of latanoprost, a common drug used for the treatment of glaucoma, the leading cause of irreversible blindness worldwide.
Researchers from the Massachusetts Eye and Ear, Harvard Vanguard Medical Associates and Harvard Medical School Department of Ophthalmology report on the first study in 35 years that reviews the circumstances around retinal detachment after open globe injuries (OGI) and describes a new tool that may help ophthalmologists predict which patients are at higher risk after open globe trauma so they can potentially prevent retinal detachment from happening or identify – and repair – it more quickly, thus saving vision.
Meibomian gland dysfunction (MGD) is the leading cause of dry eye disease, which affects tens of millions of Americans. However, there is no FDA-approved treatment for MGD. Researchers from the Schepens Eye Research Institute/Massachusetts Eye and Ear and Harvard Medical School have just identified a potential therapy.
Researchers from Massachusetts Eye and Ear, Harvard Medical School, Massachusetts Institute of Technology and Massachusetts General Hospital have demonstrated, for the first time, that aspirin intake correlates with halted growth of vestibular schwannomas (also known as acoustic neuromas), a sometimes lethal intracranial tumor that typically causes hearing loss and tinnitus.
Deprivation of vision during critical periods of childhood development has long been thought to result in irreversible vision loss. Now, researchers from the Schepens Eye Research Institute/Massachusetts Eye and Ear, Harvard Medical School (HMS) and Massachusetts Institute of Technology (MIT) have challenged that theory by studying a unique population of pediatric patients who were blind during these critical periods before removal of bilateral cataracts. The researchers found improvement after sight onset in contrast sensitivity tests, which measure basic visual function and have well-understood neural underpinnings. Their results show that the human visual system can retain plasticity beyond critical periods, even after early and extended blindness.
Hemianopia, or blindness in one half of the visual field in both eyes as the result of strokes, tumors or trauma often means the end of driving. Researchers set out to determine the extent to which people with hemianopia can compensate for the lost vision when driving.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right